CraniUS LLC
Biotechnology · Baltimore, MD
BiotechnologySEC Form D
CraniUS LLC filed a Form D with the U.S. Securities and Exchange Commission on March 6, 2026, reporting $19,000,000 raised toward a $20,000,000 offering.
Incorporated in Maryland and based in Baltimore, MD, it operates in the Biotechnology sector.
Companies file a Form D within 15 days of the first sale of securities in a private offering under Regulation D — an early, public signal that CraniUS LLC has raised capital from private investors.
Browse more recently funded companies in Biotechnology.
Executives & Directors
- Chad GordonDirector
- Sharon WolfingtonDirector
- Steven KlaskoDirector
- Brian MoranDirector
- Elliot StoneDirector
- Joshua ScheinkerDirector
- Brett FriedmanDirector
- Oray Boston, Jr.Director
- Michael MaglinExecutive Officer
Recently funded in Biotechnology
Other companies that recently filed a Form D
$3.2MRaised
Goldenrod Therapeutics, Inc.
$10.0MRaised
Human Biotech, Inc.
$1.0MRaised
Optimeos Life Sciences, Inc.
$2.5MRaised
BioStem Technologies, Inc.
$10.0MRaised